Profile
Alexandre Mouradian is the founder of eureKARE SA, eureKING SA. He is currently the Chairman of Spinoza Foundation, Director of Stellate Therapeutics SAS, Director of Omne Possibile, and Director of Meletios Therapeutics SAS. He completed his undergraduate degree at ESCP Europe Campus Paris.
Alexandre Mouradian active positions
| Companies | Position | Start |
|---|---|---|
eureKARE SA
eureKARE SA BiotechnologyHealth Technology Operates as biotechnology company for microbiome and synthetic biology | Chief Executive Officer | - |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops broad-spectrum therapeutic solutions | Director/Board Member | - |
eureKING SA
eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Founder | - |
Spinoza Foundation | Chairman | - |
Omne Possibile | Director/Board Member | - |
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Develops innovative micro biome medicine for age related deceases | Director/Board Member | - |
Training of Alexandre Mouradian
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 7 |
|---|---|
ESCP Europe Campus Paris
ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Develops innovative micro biome medicine for age related deceases | Health Technology |
Omne Possibile | |
eureKARE SA
eureKARE SA BiotechnologyHealth Technology Operates as biotechnology company for microbiome and synthetic biology | Health Technology |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops broad-spectrum therapeutic solutions | Health Technology |
eureKING SA
eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
Spinoza Foundation |
- Stock Market
- Insiders
- Alexandre Mouradian
















